JX-594
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for JX-594, covering 2014-09-17 to 2026-07-08. Get the full timeline:
Most recent: Clinical Trial Results: Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal Carcinoma [Phase 1]